Clinical Trial Update: Clinical Study of Universal CD19 CAR-γδ T Cell Infusion in the Treatment of Relapsed/Refractory Acute B Lymphoblastic Leukemia [Phase 1]

View source ↗

Summary

Phase 1 clinical study evaluating universal CD19 CAR-γδ T cell infusion for relapsed/refractory acute lymphoblastic leukemia (B-cell lineage). Status: not yet r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• Universal CD19 CAR-γδ T cell infusion (CAR-γδ T cell therapy targeting CD19)

Snippet

Sponsor: Fujian Medical University | Conditions: Relapsed/Refractory CD19-positive B-ALL | Phase 1 | Status: NOT_YET_RECRUITING